Treatment burden of vision loss in severe nearsightedness
Part of Eyes & vision clinical trials.
This study looks at the treatment experience for people with severe nearsightedness who develop abnormal blood vessels under the retina, which can cause vision loss. It aims to understand how much treatment is needed and what patients go through.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe nearsightedness (more than 6 diopters or eye length over 26 mm)
- You have been diagnosed with a type of vision loss called myopic choroidal neovascularization, which is new abnormal blood vessels under the retina
- The abnormal blood vessels are under or near the center of your vision (subfoveal or juxtafoveal)
- You have not had any treatment for this condition yet
- Only one eye per patient is included, so if both eyes are affected, only the first eye treated is counted
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses detailed eye scans (OCT and OCTA) to predict how well anti-VEGF injections will work in the long run for people with high myopia and an eye condition called myopic choroidal neovascularization (abnormal blood vessel growth caused by myopia). If you fit the criteria, participating could help doctors know if these injections are a good option for you.
This study is looking for biomarkers (clues in your body) related to abnormal blood vessels in the eye. It may help researchers understand and treat conditions like macular degeneration.
This study looks at how people with severe nearsightedness (high myopia) and specific changes in the back of the eye manage everyday tasks like reading and driving. You'll answer questionnaires and may use a driving simulator to help doctors understand what you need.
This study follows people with high myopia over time to monitor their eye health. It aims to better understand how very nearsighted eyes change.
This study looks at how well people with nearsightedness see and what factors affect their visual quality. It may help doctors understand how to improve vision care for people with myopia.
This trial tests a combination of two treatments—a heat procedure and a medication injection—to reduce abnormal blood vessel growth on the clear front surface of your eye (cornea). The goal is to improve your vision and prevent further damage.
Hear when a new Burden trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.